SuperworthImmunovant shares outstanding IMVT
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 205.5M
- On a year earlier
- +20.3%
- more shares
Immunovant had 205.5M diluted shares outstanding on average in Q1 FY27, the quarter to Jun 30, 2026.
That is 20.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 203.8M | +22% |
| FY2025 | 166.9M | +15% |
| FY2024 | 145.7M | +12% |
| FY2023 | 130.4M | +12% |
| FY2022 | 116.5M | +19% |
| FY2021 | 98M | +79% |
| FY2020 | 54.7M | +2086% |
| FY2019 | 2.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY27 | 205.5M | +20% | |
| Q4 FY26 | 203.8M | +22% | |
| Q3 FY26 | 181.5M | +24% | |
| Q2 FY26 | 173.6M | +19% | |
| Q1 FY26 | 170.9M | +17% | |
| Q4 FY25 | 166.9M | +15% | |
| Q3 FY25 | 146.9M | +2% | |
| Q2 FY25 | 146.5M | +12% | |
| Q1 FY25 | 146.1M | +12% | |
| Q4 FY24 | 145.7M | +12% | |
| Q3 FY24 | 144.5M | +12% | |
| Q2 FY24 | 131.2M | +13% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Immunovant
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.